# Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder

> **NCT02129816** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Zurich** · enrollment: 9 (actual)

## Conditions studied

- Overactive Bladder
- Urge Urinary Incontinence

## Interventions

- **DRUG:** Bryophyllum

## Key facts

- **NCT ID:** NCT02129816
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05
- **Primary completion:** 2016-04-20
- **Final completion:** 2017-07-09
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-10-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02129816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02129816, "Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02129816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*